SAN ANTONIO — Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug [...]
ROCHESTER, Minn. — Inherited pathogenic variants in protein coding genes BARD1 and RAD51D increase a woman’s likelihood of developing breast cancer, according to research [...]
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug [...]
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, according to a study presented at [...]
SAN ANTONIO — Mayo Clinic researchers will present findings at the San Antonio Breast Cancer Symposium Dec. 10–14 in San Antonio.
Clinic studies [...]